PET-CT Based Radiotherapy in Esophageal Cancer Patients
NCT01156831 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 115
Last updated 2014-12-08
Summary
The purpose of this study is to determine the locoregional control in PET/CT based radiotherapy treatment planning in the treatment of esophageal cancer patients.
Conditions
- Esophageal Neoplasms
Sponsors & Collaborators
-
Maastricht Radiation Oncology
lead OTHER
Principal Investigators
-
Guido Lammering, MD PhD · Radiation Oncology, Maastro Clinic
-
Meindert Sosef, MD PhD · Atrium Hospital Heerlen
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-11-30
- Primary Completion
- 2011-05-31
- Completion
- 2013-05-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Dynamic and Test-retest Whole Body [18F]FES PET Imaging in Patients With Metastatic ER+ Breast Cancer
NCT05088785 ·Status: RECRUITING ·Phase: NA
-
Prediction of Lymphatic Metastasis in Esophageal Cancer by CT Radiomics
NCT03237130 ·Status: COMPLETED
-
89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study
NCT05955833 ·Status: UNKNOWN ·Phase: PHASE1
-
PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
NCT03791905 ·Status: UNKNOWN ·Phase: PHASE2
-
Predicting Esophageal Cancer Borders Using PET-Imaging
NCT06408116 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer
NCT04161781 ·Status: COMPLETED
-
MR/PET in the Evaluation of Patients With Esophageal Cancer
NCT02547610 ·Status: UNKNOWN
-
[18F]FES PET/CT in Endocrine Refractory Breast Cancer
NCT02409316 ·Status: COMPLETED ·Phase: PHASE2
-
The Value of 18F-FES-PET/CT in Predicting Fulvestrant Efficacy in Breast Cancer
NCT03768479 ·Status: UNKNOWN ·Phase: NA
-
Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors
NCT00163176 ·Status: COMPLETED
-
Non-invasive Imaging of Cetuximab-Zr. 89 Uptake Wit PET: a Phase I Trial in Stage IV Cancer Patients
NCT00691548 ·Status: COMPLETED ·Phase: PHASE1
-
FDG-PET-CT and Biomarkers in Esophageal Cancer
NCT00833625 ·Status: COMPLETED ·Phase: NA
-
Imaging of ER Density to Guide and Improve Tailored Therapy for Acquired Anti-hormonal Resistant Breast Cancer
NCT01088477 ·Status: COMPLETED
-
Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)
NCT01308905 ·Status: UNKNOWN ·Phase: NA
-
A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer
NCT01051479 ·Status: COMPLETED ·Phase: PHASE1
-
68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients
NCT02327442 ·Status: UNKNOWN
-
FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET
NCT03726931 ·Status: COMPLETED ·Phase: NA
-
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer
NCT03442504 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessment of Response to nCRT for GEJ Cancer Using a Fully Integrated PET/MRI
NCT04359732 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PET-CT vs DWI-MRI in Response Evaluation in Esophageal Cancer
NCT02839109 ·Status: COMPLETED
-
Interventional X-ray and Scintigraphy Imaging of 99mTc-MAA During the Radioembolisation Pretreatment Procedure
NCT06013774 ·Status: COMPLETED ·Phase: NA
-
AR and ER Imaging in Metastatic Breast Cancer
NCT01988324 ·Status: COMPLETED ·Phase: PHASE2
-
PET With [18F]HX4 in Head and Neck Cancer
NCT01347281 ·Status: COMPLETED ·Phase: NA
-
Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma
NCT05681234 ·Status: COMPLETED ·Phase: NA
-
The Utility of FDG-PET for Radiation Treatment in NSCLC
NCT00385164 ·Status: UNKNOWN